These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1997737)

  • 1. Morphology of menstrual hemostasis in essential menorrhagia.
    van Eijkeren MA; Christiaens GC; Geuze JJ; Haspels AA; Sixma JJ
    Lab Invest; 1991 Feb; 64(2):284-94. PubMed ID: 1997737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia.
    van Eijkeren MA; Christiaens GC; Geuze HJ; Haspels AA; Sixma JJ
    Am J Obstet Gynecol; 1992 May; 166(5):1419-28. PubMed ID: 1595797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphology of the hemostatic plug in human skin wounds: transformation of the plug.
    Wester J; Sixma JJ; Geuze JJ; Heijnen HF
    Lab Invest; 1979 Aug; 41(2):182-92. PubMed ID: 459434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The morphologic characteristics of menstrual hemostasis in patients with unexplained menorrhagia.
    Hourihan HM; Sheppard BL; Bonnar J
    Int J Gynecol Pathol; 1989; 8(3):221-9. PubMed ID: 2767871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphology of the early hemostasis in human skin wounds: influence of acetylsalicylic acid.
    Wester J; Sixma JJ; Geuze JJ; van der Veen J
    Lab Invest; 1978 Sep; 39(3):298-311. PubMed ID: 362066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The haemostatic mechanism and menstruation: the role of intra-uterine contraceptive devices.
    Rajah SM; Foley ME; Clayton JK; Aparicio SR; Bird CC; McNicol GP
    Thromb Haemost; 1980 Feb; 42(5):1548-56. PubMed ID: 7368156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder.
    Fraser IS; McCarron G; Markham R; Resta T; Watts A
    Obstet Gynecol; 1986 Nov; 68(5):630-3. PubMed ID: 3763074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
    Hefnawi F; Saleh A; Kandil O; El-Sheikha Z; Hassanein M; Askalani H
    Int J Gynaecol Obstet; 1979; 16(5):400-7. PubMed ID: 35409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
    Pan J; Yu Y; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
    Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
    Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple visual assessment technique to discriminate between menorrhagia and normal menstrual blood loss.
    Janssen CA; Scholten PC; Heintz AP
    Obstet Gynecol; 1995 Jun; 85(6):977-82. PubMed ID: 7770270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding.
    Kouides PA; Conard J; Peyvandi F; Lukes A; Kadir R
    Fertil Steril; 2005 Nov; 84(5):1345-51. PubMed ID: 16275228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of menstrual flow by weighing protective pads in women with normal, decreased or increased menstruation.
    Gudmundsdottir BR; Hjaltalin EF; Bragadottir G; Hauksson A; Geirsson RT; Onundarson PT
    Acta Obstet Gynecol Scand; 2009; 88(3):275-9. PubMed ID: 19137461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pathology of dysfunctional uterine bleeding.
    Sheppard BL
    Clin Obstet Gynaecol; 1984 Apr; 11(1):227-36. PubMed ID: 6370534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between measured menstrual blood loss and patient's subjective assessment of loss, duration of bleeding, number of sanitary towels used, uterine weight and endometrial surface area.
    Chimbira TH; Anderson AB; Turnbull Ac
    Br J Obstet Gynaecol; 1980 Jul; 87(7):603-9. PubMed ID: 7426516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphology of haemostasis in menstrual endometrium.
    Christiaens GC; Sixma JJ; Haspels AA
    Br J Obstet Gynaecol; 1980 May; 87(5):425-39. PubMed ID: 6992851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Menorrhagia and hemostatic abnormalities: diagnosis and treatment].
    Gueddi S; Boehlen F; de Ziegler D; de Moerloose P
    Rev Med Suisse; 2005 Jan; 1(4):279-82. PubMed ID: 15771356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of mefenamic acid and norethisterone on measured menstrual blood loss.
    Cameron IT; Haining R; Lumsden MA; Thomas VR; Smith SK
    Obstet Gynecol; 1990 Jul; 76(1):85-8. PubMed ID: 2359570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative factors for predicting successful hysteroscopic endometrial ablation.
    Gemer O; Kapustian V; Kroll D; Tur-Kaspa I; Segal S
    J Reprod Med; 2003 Sep; 48(9):677-80. PubMed ID: 14562630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.